Article Details

Intercept Pharmaceuticals (NASDAQ:ICPT) Earns Buy Rating from Raymond James

Retrieved on: 2019-06-09 10:48:45

Tags for this article:

Click the tags to see associated articles and topics

Intercept Pharmaceuticals (NASDAQ:ICPT) Earns Buy Rating from Raymond James. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> raised its stake in shares of Intercept Pharmaceuticals by 234.5% in the first quarter. <b>Man Group plc</b> now owns 15,927 shares of the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo